Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations.

Kohn EC, Figg WD, Sarosy GA, Bauer KS, Davis PA, Soltis MJ, Thompkins A, Liotta LA, Reed E.

J Clin Oncol. 1997 May;15(5):1985-93.

PMID:
9164210
2.

Identification and characterization of human metabolites of CAI [5-amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole- 4-carboxamide).

Soltis MJ, Yeh HJ, Cole KA, Whittaker N, Wersto RP, Kohn EC.

Drug Metab Dispos. 1996 Jul;24(7):799-806.

PMID:
8818579
3.

Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transduction.

Figg WD, Cole KA, Reed E, Steinberg SM, Piscitelli SC, Davis PA, Soltis MJ, Jacob J, Boudoulas S, Goldspiel B, et al.

Clin Cancer Res. 1995 Aug;1(8):797-803.

Supplemental Content

Loading ...
Support Center